Omeros Corporation News
The Case For a Biotech Snapback
After a challenging year, shares of biotech companies could see rebound following tax loss selling, Bret Jensen says.
Reflecting on 9/11: Cramer's 'Mad Money' Recap
Jim Cramer says he believes we are today better prepared for both the terror and the financial attacks that America endured on 9/11.
Cypress Semiconductor, Omeros, Zuora: 'Mad Money' Lightning Round
Jim Cramer weighs in on Cypress Semiconductor, Omeros, Zuora, Kemet, Leidos, Raytheon, and Skyworks Solutions.
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
Despite lobbying hard for changes, the pharmaceutical industry is going to cover more costs regarding Medicare Part D in the $1.3 trillion budget that needs to pass by Friday.
Omeros Shares Lower After Completing Stock Offering - Biotech Movers
The Seattle firm said Aug. 21 it completed an underwritten public offering of 3 million shares priced at $22.75 apiece.
Biotech Movers: BioCryst, Omeros, Radius Health
BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.
Biotech Movers: Organovo, Endo, Omeros
Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.
Biotech Movers: OncoMed, Incyte, Omeros
OncoMed Pharmaceuticals, Incyte and Omeros were among the biotech stock movers in premarket trading on Monday.
Freeport McMoRan, Wix, Zions Bancorporation: 'Mad Money' Lightning Round
Jim Cramer says hold off before jumping into Freeport McMoRan, Wix.com and Zions Bancorporation.
Breaking News
Target Brings New Designer Brands to Its Stores
Target brings in a famous partner to expand designs.
Chick-fil-A Offers a New Dining Experience
Chick-fil-A is offering more variety in a new concept.
Billionaire Gautam Adani Loses $26 Billion
The Indian tycoon and his empire are facing allegations of fraud by an American short-seller. Their answer does not convince investors for the moment.
Elon Musk Has Questions About the War in Ukraine
The billionaire had proposed a controversial plan to end the Russia-Ukraine conflict, which now has lasted nearly a year.